Client Background

Millions of people around the world take daily oral medication to relieve acid reflux. This Bay Area medical device start-up acquired a novel technology from a vascular company to treat Gastroesophageal Reflux Disease (GERD) with an endovascular approach.

Client Challenge

The product offering involved a unique catheter delivery system, used to deliver an embolic agent to bulk the esophageal sphincter muscle.

LSO’s Role

LSO provided packaging development services, packaging, and sterilization validation.

Client Results

The company had successful clinical results, received their FDA approval, and were acquired by a multinational company within four years.